PD-L1 Ameliorates Murine Acute Graft-Versus-Host Disease by Suppressing Effector But Not Regulatory T Cells Function
- 29 March 2019
- journal article
- research article
- Published by Walter de Gruyter GmbH in Archivum Immunologiae et Therapiae Experimentalis
- Vol. 67 (3) , 179-187
Abstract
There is increasing evidence that interaction between programmed death 1 (PD-1) and its ligands PD-1 (PD-L1) plays a critical role in the pathology of acute graft-versus-host disease (aGVHD). However, the role of PD-L1 in the development of aGVHD has been controversial in recent mouse studies. In this study, we carried out studies in a murine aGVHD model to clarify the role of PD-L1 in aGVHD pathogenesis. We found that systemic overexpression of PD-L1 by hydrodynamic gene transfer (HGT) method in vivo ameliorates aGVHD-induced lethality in mice. Systemic overexpression of PD-L1 inhibits the donor T cells activation, effector memory status, as well as Th1 and Th17 cells responses in vivo. In addition, PD-L1 Ig treatment significantly suppressed T cells’ proliferation, promoted T cells’ apoptosis, and reduced pro-inflammatory cytokines expression by effector T cells in vitro in the stimulation of anti-CD3/CD28 and allogeneic dendritic cells. However, we found that PD-L1 overexpression did not affect Treg cells’ differentiation in vivo and in vitro, depletion of Treg cells in PD-L1 HGT recipients did not aggravate aGVHD mortality. Therefore, our results demonstrated that systemic treatment with PD-L1 protein ameliorates aGVHD by suppressing effector but not regulatory T cell function. Our findings suggest that systemic treatment with PD-L1 may be a potential strategy to prevent or ameliorate aGVHD.Keywords
Funding Information
- National Natural Science Foundation of China (81500145, 81570138, 81700173)
- Excellent Young Talents Fund Program of Higher Education Institutions of Anhui Province (PAPD)
- The Innovation Capability Development Project of Jiangsu Province (No. BM2015004)
- Agence Nationale pour le Développement de la Recherche en Santé (2016YFC0902800, 2017YFA0104502, 2017ZX09304021)
- Jiangsu Provincial Key Medical Center (YXZXA2016002)
- Suzhou Science and Technology Development Plan (sys2018027)
This publication has 33 references indexed in Scilit:
- Regulation of GVHD and GVL Activity via PD-L1 Interaction With PD-1 and CD80Frontiers in Immunology, 2018
- Adoptively transferred donor IL-17-producing CD4+ T cells augment, but IL-17 alleviates, acute graft-versus-host diseaseCellular & Molecular Immunology, 2016
- B7H1/CD80 Interaction Augments PD-1–Dependent T Cell Apoptosis and Ameliorates Graft-versus-Host DiseaseThe Journal of Immunology, 2015
- Programmed Death-1 Pathway in Host Tissues Ameliorates Th17/Th1-Mediated Experimental Chronic Graft-versus-Host DiseaseThe Journal of Immunology, 2014
- Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantationBlood, 2011
- Alloantigen expression on non-hematopoietic cells reduces graft-versus-leukemia effects in miceJournal of Clinical Investigation, 2010
- PD-L1 regulates the development, maintenance, and function of induced regulatory T cellsJournal of Experimental Medicine, 2009
- Blockade of Programmed Death-1 Engagement Accelerates Graft-Versus-Host Disease Lethality by an IFN-γ-Dependent MechanismThe Journal of Immunology, 2003
- Engagement of the Pd-1 Immunoinhibitory Receptor by a Novel B7 Family Member Leads to Negative Regulation of Lymphocyte ActivationJournal of Experimental Medicine, 2000
- B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretionNature Medicine, 1999